Peter Johnsen
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Peter Holger Johnsen, MD, is an Internal Medicine physician at the University Hospital of North Norway, Harstad, Norway. He states that myalgic encephalomyelitis/ chronic fatigue syndrome may be caused by a disorder in the natural intestinal flora possibly from a leak of bacterial products from the intestine.[1]
Dr Johnsen is conducting a clinical trial funded by the Norwegian Health Council on the use of fecal microbiota transplant (FMT) on the treatment of myalgic encephalomyelitis/ chronic fatigue syndrome.[2]
Notable studies[edit | edit source]
- 2017, Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial[3] (Abstract)
Talks and interviews[edit | edit source]
- 1 Jun 2018, Speaker at the 13th Invest in ME International ME Conference on "Double blinded, single center, placebo controlled, randomized clinical trial treating ME with FMT"[4]
Online presence[edit | edit source]
Learn more[edit | edit source]
- Forskningsjubel for tarmprosjekt for ME-syke (Research appeals for intestinal care for ME patients)
See also[edit | edit source]
References[edit | edit source]
- ↑ https://www.pingvinavisa.no/forskningsjubel-tarmprosjekt-me-syke/
- ↑ https://www.pingvinavisa.no/forskningsjubel-tarmprosjekt-me-syke/
- ↑ Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. (2017). Johnsen, Peter Holger et al. The Lancet Gastroenterology & Hepatology, Volume 3, Issue 1, 17-24. DOI: 10.1016/S2468-1253(17)30338-2
- ↑ http://www.investinme.org/IIMEC13-13-13-Agenda.shtml
